Company: PTHS
Filing Date: 2025-08-28
Form Type: S-3
Source: 0001753926-25-001403
Chunk: 77

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-28
Form: S-3
Chunk 77
---
 Stock in order to permit the Selling Stockholders to offer the shares for resale from time to time.

The table below lists the Selling Stockholders
and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), and the rules and regulations thereunder) of the shares of Common Stock held
by each of the Selling Stockholders. The second column lists the number of shares of Common Stock beneficially owned by the Selling
Stockholders, based on their respective ownership of shares of Common Stock and Series A Preferred Stock, as of August 20, 2025,
assuming conversion of the Series A Preferred Stock held by each such Selling Stockholder on that date but taking account of any
limitations on conversion set forth therein.

The third column lists the shares of Common Stock being offered by this prospectus by the Selling Stockholders and does not take in account any limitations on conversion of the Series A Preferred Stock set forth therein.

In accordance with the terms of a registration rights agreement with the holders of the Series A Preferred Stock, this prospectus generally covers the resale of 100% of the maximum number of shares of Common Stock issued or issuable pursuant to the Certificate of Designations (with the maximum number of shares of Common Stock issued determined as if the outstanding Series A Preferred Stock were converted in full (without regard to any limitations on conversion contained therein solely for the purpose of such calculation) at a conversion price calculated as of the trading day immediately preceding the date this registration statement was initially filed with the SEC). Because the conversion price of the Series A Preferred Stock may be adjusted, the number of shares of Common Stock that will actually be issued may be more or less than the number of shares of Common Stock being offered by this prospectus. The fourth column assumes the sale of all of the shares of Common Stock offered by the Selling Stockholders pursuant to this prospectus.

<div align='center'>44</div>

Under the terms of the Series A Preferred Stock, a Selling Stockholder may not convert the Series A Preferred Stock to the extent (but only to the extent) such Selling Stockholder or any of its affiliates would beneficially own a number of shares of our Common Stock which would exceed 4.99 or 49.99% of the outstanding shares of the Company, as applicable. The number of shares of Common Stock in the second column reflects these limitations. The Selling Stockholders may sell all, some or none of their shares of Common Stock